Phenylpropylaminopentane (-)-1-Phenyl-2-propylaminopentane (-)-PPAP CAS: 784118-64-5

CAS NO: 784118-64-5
Chemical Name :
Molecular Formula: C14H23N
CAS No.: 784118-64-5
Formula Weight: 205.35
CBNumber: CB43110641
Description Review

(-)-1-Phenyl-2-propylaminopentane (also known as (-)-PPAP and N,-dipropylphenethylamine) is a substituted phenethylamine stimulant and a derivative of Selegiline. (-)-PPAP has a distinct method of action and pharmacological impact when compared to Selegiline and other substituted phenethylamines.

PPAP is characterized as an enhancer of catecholaminergic and serotonergic action. This implies that it increases the neurotransmitters dopamine, noradrenaline, and serotonin in the brain via impulse propagation mediated transmitter release (although unlike the newer and more potent compound BPAP it has less impact on serotonin release and affects mainly dopamine and noradrenaline). Unlike stimulant medicines like amphetamines, which cause an uncontrolled flood of monoamine neurotransmitters to be produced, PPAP only increases the quantity of neurotransmitter released when a neuron is activated by receiving an input from a neighboring neuron. While both amphetamines and PPAP stimulate neurotransmitter release, amphetamines lead neurons to discharge neurotransmitter reserves into the synapse independent of external stimulation.The pattern of neurotransmitter release is not altered by PPAP, but when the cell would usually release neurotransmitter, a greater quantity than usual is released.

Phenylpropylaminopentane, commonly known as Phenylpiracetam or Carphedon, is a nootropic and a psychostimulant drug that was first developed in Russia in the 1980s. It is a derivative of the neurotransmitter GABA (gamma-aminobutyric acid), and is used to improve cognitive function, memory, and concentration.

Top Searched Keywords on Google and Synonyms on google:

  • Phenylpiracetam benefits
  • Phenylpiracetam dosage
  • Phenylpiracetam effects
  • Carphedon
  • Phenotropil
  • Fonturacetam
  • Noopept++

Health Benefits: Phenylpiracetam has been shown to have a variety of health benefits, particularly in the area of cognitive enhancement. It is believed to work by increasing the production and release of neurotransmitters in the brain, particularly dopamine, which is associated with improved mood and motivation.

One of the primary benefits of Phenylpiracetam is its ability to improve cognitive function and memory. Studies have shown that it can enhance both long-term and short-term memory, particularly in tasks that require recall of visual and auditory information.

Phenylpiracetam has also been shown to improve concentration and focus, particularly in tasks that require sustained attention, such as studying or working on a project over an extended period of time. This makes it a popular choice for students and professionals looking to boost their productivity and performance.

Potential Effects: Some potential effects of Phenylpiracetam include increased energy and alertness, improved mood, and reduced fatigue. It may also increase motivation and drive, and improve athletic performance.

Mechanisms: The exact mechanisms by which Phenylpiracetam works are not fully understood, but it is believed to increase the activity of the neurotransmitter dopamine, which is associated with enhanced cognitive function, mood, and motivation. It may also enhance the activity of acetylcholine, a neurotransmitter that is involved in memory and learning.

Safety: Phenylpiracetam is generally considered safe when taken as directed. However, it may cause side-effects in some individuals, particularly at higher doses. It is important to consult with a healthcare professional before taking this supplement, particularly if you have any underlying medical conditions or are taking any medications.

Side-Effects: Common side effects of Phenylpiracetam include headaches, insomnia, and anxiety. It may also cause gastrointestinal symptoms, such as nausea and diarrhea. In rare cases, it may cause more serious side effects, such as rapid heart rate or seizures. If you experience any adverse effects, it is important to stop taking the supplement and consult with a healthcare professional.

Dosage Information: The recommended dosage of Phenylpiracetam varies depending on the individual and the reason for use. It is important to start with a low dose and gradually increase as needed, and to always follow the recommended dosage guidelines on the packaging. Typical dosages range from 100 to 200 mg per day, taken either in a single dose or divided into several smaller doses throughout the day.

In conclusion, Phenylpiracetam is a powerful nootropic and psychostimulant drug that has a variety of cognitive-enhancing and mood-boosting benefits. While it is generally considered safe when taken as directed, it may cause side effects in some individuals and should be used with caution. It is important to consult with a healthcare professional before taking Phenylpiracetam or any other dietary supplement.


Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
Message Us